JNJ

Johnson & Johnson
D

JNJ

Arincen70/100B

Johnson & Johnson income statement 1985–2026

99.34B USD over the last twelve months, and 94.19B USD in fiscal year 2025.

Revenue Operating income Net income

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
27 Sept 2026
FY2025
28 Dec 2025
FY2024
29 Dec 2024
FY2023
31 Dec 2023
FY2022
1 Jan 2023
FY2021
2 Jan 2022
FY2020
3 Jan 2021
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Revenue
99.34B94.19B88.82B85.16B79.99B78.74B82.58B82.06B81.58B76.45B71.89B
Revenue growth
+7.80%+6.05%+4.30%+6.46%+1.59%-4.65%+0.64%+0.59%+6.71%+6.34%+2.59%
Cost of revenue
30.98B30.26B27.47B26.55B24.60B23.40B28.43B27.56B27.09B25.44B21.79B
Gross profit
68.35B63.94B61.35B58.61B55.39B55.34B54.16B54.50B54.49B51.01B50.10B
Gross margin
68.81%67.88%69.07%68.82%69.25%70.28%65.58%66.42%66.79%66.72%69.69%
Research and development
16.08B14.67B17.23B15.09B14.14B14.28B12.34B11.36B10.78B10.59B9.14B
Selling, general and administrative
25.50B23.68B21.97B20.11B20.25B20.12B22.08B22.18B22.54B21.52B20.07B
Operating expenses
42.83B38.34B39.20B35.20B34.38B34.40B34.42B33.53B33.32B32.11B29.21B
25.53B25.60B22.15B23.41B21.01B20.94B19.73B20.97B21.18B18.90B20.89B
Operating income growth
+6.15%+15.56%-5.38%+11.40%+0.33%+6.13%-5.90%-0.97%+12.05%-9.54%+14.23%
Operating margin
25.70%27.17%24.94%27.49%26.27%26.60%23.89%25.55%25.96%24.72%29.06%
Interest income
—1.06B1.33B1.26B490.00M53.00M111.00M357.00M611.00M385.00M368.00M
Interest expense
798.00M971.00M755.00M772.00M276.00M183.00M201.00M318.00M1.01B934.00M726.00M
Other non-operating income
-7.79B6.99B-5.46B-8.35B-1.65B-1.77B-3.24B-3.64B-3.18B-1.22B-1.09B
Pretax income
17.74B32.58B16.69B15.06B19.36B19.18B16.50B17.33B18.00B17.67B19.80B
Income tax
1.64B5.78B2.62B1.74B2.99B1.38B1.78B2.21B2.70B16.37B3.26B
Effective tax rate
9.26%17.73%15.71%11.53%15.44%7.18%10.81%12.75%15.01%92.64%16.48%
16.10B26.80B14.07B35.15B17.94B20.88B14.71B15.12B15.30B1.30B16.54B
Net income growth
-35.93%+90.56%-59.99%+95.94%-14.07%+41.89%-2.68%-1.16%+1,076.69%-92.14%+7.34%
Net margin
16.20%28.46%15.84%41.28%22.43%26.52%17.82%18.42%18.75%1.70%23.01%
Basic shares
2.44B2.43B2.41B2.53B2.61B2.63B2.63B2.63B2.66B2.68B2.71B
Diluted shares
2.44B2.43B2.43B2.56B2.66B2.67B2.67B2.68B2.73B2.75B2.79B
Change in diluted shares
+0.77%0.00%-5.12%-3.89%-0.38%+0.12%-0.51%-1.63%-0.60%-1.56%-0.85%
EPS (basic)
6.6011.035.8413.886.837.935.595.745.750.486.08
EPS (diluted)
6.6011.035.7913.726.737.815.515.635.610.475.93
EPS growth
-36.33%+90.50%-57.80%+103.86%-13.83%+41.74%-2.13%+0.36%+1,093.62%-92.07%+8.21%
Dividends per share
5.285.144.914.704.454.193.983.753.543.323.15
Dividend growth
+3.94%+4.68%+4.47%+5.62%+6.21%+5.28%+6.13%+5.93%+6.63%+5.40%+6.78%
EBITDA
30.81B41.06B24.78B23.32B26.61B26.75B23.93B24.66B25.93B24.25B24.28B
EBITDA margin
31.02%43.59%27.90%27.38%33.26%33.97%28.98%30.05%31.79%31.72%33.78%
EBIT
24.84B33.55B17.44B15.83B19.64B19.36B16.70B17.65B19.00B18.61B20.53B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Johnson & Johnson's income statement

Source: Financial Modeling PrepVerified against SEC filings